Interferon-γ exposure of human iPSC-derived neurons alters major histocompatibility complex I and synapsin protein expression.
C4A
MHCI
iPSC
inflammation
interferon-γ
maternal immune activation
schizophrenia
synapsin
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2022
2022
Historique:
received:
15
12
2021
accepted:
18
08
2022
entrez:
3
10
2022
pubmed:
4
10
2022
medline:
4
10
2022
Statut:
epublish
Résumé
Human epidemiological data links maternal immune activation (MIA) during gestation with increased risk for psychiatric disorders with a putative neurodevelopmental origin, including schizophrenia and autism. Animal models of MIA provide evidence for this association and suggest that inflammatory cytokines represent one critical link between maternal infection and any potential impact on offspring brain and behavior development. However, to what extent specific cytokines are necessary and sufficient for these effects remains unclear. It is also unclear how specific cytokines may impact the development of specific cell types. Using a human cellular model, we recently demonstrated that acute exposure to interferon-γ (IFNγ) recapitulates molecular and cellular phenotypes associated with neurodevelopmental disorders. Here, we extend this work to test whether IFNγ can impact the development of immature glutamatergic neurons using an induced neuronal cellular system. We find that acute exposure to IFNγ activates a signal transducer and activator of transcription 1 (STAT1)-pathway in immature neurons, and results in significantly increased major histocompatibility complex I (MHCI) expression at the mRNA and protein level. Furthermore, acute IFNγ exposure decreased synapsin I/II protein in neurons but did not affect the expression of synaptic genes. Interestingly, complement component 4A (
Identifiants
pubmed: 36186864
doi: 10.3389/fpsyt.2022.836217
pmc: PMC9515429
doi:
Types de publication
Journal Article
Langues
eng
Pagination
836217Subventions
Organisme : Medical Research Council
ID : MR/N026063/1
Pays : United Kingdom
Informations de copyright
Copyright © 2022 Pavlinek, Matuleviciute, Sichlinger, Dutan Polit, Armeniakos, Vernon and Srivastava.
Déclaration de conflit d'intérêts
Authors AV and DS receive research funding from bit.bio. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Mol Cell. 2014 Oct 23;56(2):193-204
pubmed: 25242146
Biol Psychiatry. 2021 Mar 1;89(5):486-496
pubmed: 32826066
Brain Behav Immun. 2015 Mar;45:60-70
pubmed: 25449671
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Cell Biol. 1999 Feb 8;144(3):507-18
pubmed: 9971745
Nat Neurosci. 2011 Apr;14(4):442-51
pubmed: 21358642
Mol Psychiatry. 2018 Apr;23(4):1001-1013
pubmed: 28322282
Nat Neurosci. 2021 Jun;24(6):799-809
pubmed: 33958802
Brain Behav Immun. 2013 Jul;31:54-68
pubmed: 22841693
eNeuro. 2018 Aug 29;5(4):
pubmed: 30225350
Lancet Psychiatry. 2020 Mar;7(3):254-261
pubmed: 32035031
Cell Res. 2006 Jan;16(1):113-23
pubmed: 16467883
Biol Psychiatry. 2018 Jan 15;83(2):109-119
pubmed: 28754515
Mol Psychiatry. 2021 Feb;26(2):396-410
pubmed: 33230204
Dev Neurobiol. 2021 Jul;81(5):524-545
pubmed: 33382515
J Neurosci. 2002 Jun 1;22(11):4530-9
pubmed: 12040060
Trends Neurosci. 2019 Nov;42(11):793-806
pubmed: 31493924
Prog Neurobiol. 2017 Sep;156:149-163
pubmed: 28528956
Neuron. 2013 Jun 5;78(5):785-98
pubmed: 23764284
Neuron. 2019 Jul 17;103(2):217-234.e4
pubmed: 31171447
Front Psychiatry. 2020 Feb 26;11:72
pubmed: 32174851
Arch Gen Psychiatry. 2000 Jan;57(1):65-73
pubmed: 10632234
J Neurosci. 2013 Aug 21;33(34):13791-804
pubmed: 23966700
J Neurosci. 2007 Oct 3;27(40):10695-702
pubmed: 17913903
Stem Cell Reports. 2017 Apr 11;8(4):803-812
pubmed: 28344001
Stem Cell Reports. 2021 Sep 14;16(9):2118-2127
pubmed: 34358451
Neuron. 2009 Oct 15;64(1):40-5
pubmed: 19840547
Brain Behav Immun. 2019 Aug;80:406-418
pubmed: 30980948
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
J Biol Chem. 2007 Jul 13;282(28):20059-63
pubmed: 17502367
Biol Psychiatry Cogn Neurosci Neuroimaging. 2022 Jan;7(1):24-33
pubmed: 33766778
Nature. 2016 Jul 21;535(7612):425-9
pubmed: 27409813
Mol Cell Neurosci. 2020 Mar;103:103463
pubmed: 31917333
Biol Psychiatry. 2014 Feb 15;75(4):262-8
pubmed: 24199663
Nature. 2014 May 8;509(7499):195-200
pubmed: 24695230
Nat Neurosci. 2018 May;21(5):765-772
pubmed: 29632361
Schizophr Res. 2001 Jan 15;47(1):27-36
pubmed: 11163542
Nat Neurosci. 2021 Feb;24(2):214-224
pubmed: 33353966
Immunol Rev. 2022 Oct;311(1):187-204
pubmed: 35656941
Nature. 2016 Feb 11;530(7589):177-83
pubmed: 26814963
Brain Behav Immun. 2015 Aug;48:139-46
pubmed: 25816799
Cereb Cortex. 2016 Apr;26(4):1453-1463
pubmed: 25316337
J Neuroinflammation. 2018 May 26;15(1):165
pubmed: 29803226
Sci Adv. 2020 Aug 19;6(34):eaay9506
pubmed: 32875100
Mol Psychiatry. 2021 Jun;26(6):1808-1831
pubmed: 32071385
Brain Behav Immun. 2015 Nov;50:249-258
pubmed: 26218293
Nature. 2009 Aug 6;460(7256):753-7
pubmed: 19571809
Mol Psychiatry. 2019 Apr;24(4):549-561
pubmed: 29511299
Immunity. 2021 Nov 9;54(11):2611-2631.e8
pubmed: 34758338
Nat Commun. 2020 Jan 14;11(1):246
pubmed: 31937764
Brain Behav Immun. 2016 Jul;55:25-38
pubmed: 26408796
Brain Behav Immun. 2018 Oct;73:643-660
pubmed: 30026057
J Neurosci. 2005 Aug 10;25(32):7299-308
pubmed: 16093379
Mol Psychiatry. 2021 Dec;26(12):7690-7698
pubmed: 34135473
Brain Behav Immun. 2020 Aug;88:619-630
pubmed: 32335198
Neuron. 2009 Nov 25;64(4):463-70
pubmed: 19945389
Genome Biol. 2006;7(10):R100
pubmed: 17076895